Title:
Design, Synthesis, DFT, docking Studies, and antimicrobial evaluation of novel benzimidazole containing sulphonamide derivatives

dc.contributor.authorKajal Singh
dc.contributor.authorVishal K. Singh
dc.contributor.authorRicha Mishra
dc.contributor.authorAshwani Sharma
dc.contributor.authorArchana Pandey
dc.contributor.authorSantosh K. Srivastava
dc.contributor.authorHimani Chaurasia
dc.date.accessioned2026-02-09T04:28:29Z
dc.date.issued2024
dc.description.abstractIn silico approaches have been employed to design a new series of benzimidazole-containing sulphonamide derivatives and qualified compounds have been synthesized to analyze their potential as antimicrobial agents. Antibacterial screening of all synthesized compounds was done using the broth microdilution method against several human pathogenic bacteria, viz. Gram-positive bacteria [B. cerus (NCIN-2156), B. subtilis (ATCC-6051), S. aureus (NCIM-2079)] and Gram-negative bacteria [P. aeruginosa (NCIM-2036), E. coli (NCIM-2065), and a drug-resistant strain of E. coli (U-621)], and the compounds presented admirable MIC values, ranging between 100–1.56 µg/mL. The combinatorial analysis showed the magnificent inhibitory efficiency of the tested compounds, acquired equipotent to ten-fold more potency compared to original MIC values. An immense synergistic effect was exhibited by the compounds during combination studies with reference drugs chloramphenicol and sulfamethoxazole was presented as fractional inhibitory concentration (∑FIC). Enzyme inhibition studies of all synthesized compounds were done by using peptidyl transferase and dihydropteroate synthase enzymes isolated from E. coli and S. aureus and each of the compound presented the admirable IC50 values, where the lead compound 3 bound to peptidyl transferase (of S. aureus with IC50 363.51 ± 2.54 µM and E. coli IC50 1.04 ± 0.08 µM) & dihydropteroate synthase (of S. aureus IC50 3.51 ± 0.82 µM and E. coli IC50 2.77 ± 0.65 µM), might account for the antimicrobial effect, exhibited excellent inhibition potential. Antifungal screening was also performed employing food poisoning methods against several pathogenic fungal species, viz A. flavus, F. oxysporum, A. niger, and A. brassicae. The obtained result indicated that few compounds can prove to be a potent drug regimen against dreaded MDR strains of microbes. Structural activity relationship (SAR) analysis and docking studies reveal that the presence of electron-withdrawing, polar, and more lipophilic substituents positively favor the antibacterial activity, whereas, electron-withdrawing, more polar, and hydrophilic substituents favor the antifungal activities. A robust coherence has been found in in-silico and in-vitro biological screening results of the compounds. © 2024 Elsevier Inc.
dc.identifier.doi10.1016/j.bioorg.2024.107473
dc.identifier.issn452068
dc.identifier.urihttps://doi.org/10.1016/j.bioorg.2024.107473
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/47565
dc.publisherAcademic Press Inc.
dc.subjectAntimicrobial
dc.subjectMDR
dc.subjectMIC
dc.subjectSAR
dc.subject∑FIC
dc.titleDesign, Synthesis, DFT, docking Studies, and antimicrobial evaluation of novel benzimidazole containing sulphonamide derivatives
dc.typePublication
dspace.entity.typeArticle

Files

Collections